Advertisement

Reactions Weekly

, Volume 1753, Issue 1, pp 305–305 | Cite as

Ruxolitinib

Erythematous skin lesions and necrotic centres on lower extremities: case report
Case report
  • 11 Downloads

Reference

  1. Dasanu CA. Erythematous skin lesions with necrotic centers on lower extremities due to the use of ruxolitinib for primary myelofibrosis. Journal of Oncology Pharmacy Practice 25: 990-992, No. 4, Jun 2019. Available from: URL: http://doi.org/10.1177/1078155218768875 - USA

Copyright information

© Springer International Publishing AG 2019

Personalised recommendations